Screening-detected pure ground-glass opacities: malignant potential beyond conventional belief?

doi:10.21037/tlcr.2020.03.19

Editorial

. 2020 Jun;9(3):816-818.

doi: 10.21037/tlcr.2020.03.19.

Screening-detected pure ground-glass opacities: malignant potential beyond conventional belief?

Peter S Y Yu¹, Joyce W Y Chan¹, Rainbow W H Lau¹, Calvin S H Ng¹

Affiliations

PMID: 32676344
PMCID: PMC7354109
DOI: 10.21037/tlcr.2020.03.19

Editorial

Screening-detected pure ground-glass opacities: malignant potential beyond conventional belief?

Peter S Y Yu et al. Transl Lung Cancer Res. 2020 Jun.

. 2020 Jun;9(3):816-818.

doi: 10.21037/tlcr.2020.03.19.

Authors

Peter S Y Yu¹, Joyce W Y Chan¹, Rainbow W H Lau¹, Calvin S H Ng¹

Affiliation

¹ Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.

PMID: 32676344
PMCID: PMC7354109
DOI: 10.21037/tlcr.2020.03.19

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr.2020.03.19). The authors have no conflicts of interest to declare.

Figures

**Figure 1**
¹⁸FDG PET-CT scan showing an elongated shaped pure GGO with maximum diameter 1.2 cm with adjacent prominent surrounding vessels in right upper lobe without FDG activity, presenting with hypermetabolic large N2 lymph nodes. CT-guided biopsy of GGO and endobronchial ultrasound biopsy of mediastinal lymph node confirmed primary lung adenocarcinoma with mediastinal lymph node metastases.

See this image and copyright information in PMC

Comment on

Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial.
Robbins HA, Katki HA, Cheung LC, Landy R, Berg CD. Robbins HA, et al. J Thorac Oncol. 2019 Sep;14(9):1662-1665. doi: 10.1016/j.jtho.2019.05.012. Epub 2019 May 22. J Thorac Oncol. 2019. PMID: 31125735 Free PMC article. Clinical Trial.

Cited by

Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.
Sadhukhan P, Ugurlu MT, Hoque MO. Sadhukhan P, et al. Cancers (Basel). 2020 Dec 18;12(12):3822. doi: 10.3390/cancers12123822. Cancers (Basel). 2020. PMID: 33352869 Free PMC article. Review.
Thoracic surgery in Hong Kong.
Chang ATC, Chan JWY, Lau RWH, Ng CSH. Chang ATC, et al. J Thorac Dis. 2022 Aug;14(8):3075-3082. doi: 10.21037/jtd-21-1600. J Thorac Dis. 2022. PMID: 36071786 Free PMC article. Review.
Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages.
Deng Y, Xia L, Zhang J, Deng S, Wang M, Wei S, Li K, Lai H, Yang Y, Bai Y, Liu Y, Luo L, Yang Z, Chen Y, Kang R, Gan F, Pu Q, Mei J, Ma L, Lin F, Guo C, Liao H, Zhu Y, Liu Z, Liu C, Hu Y, Yuan Y, Zha Z, Yuan G, Zhang G, Chen L, Cheng Q, Shen S, Liu L. Deng Y, et al. Cell Rep Med. 2024 Apr 16;5(4):101489. doi: 10.1016/j.xcrm.2024.101489. Epub 2024 Mar 29. Cell Rep Med. 2024. PMID: 38554705 Free PMC article.

References

1. Hattori A, Matsunaga T, Takamochi K, et al. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Ann Thorac Surg 2017;104:313-20. 10.1016/j.athoracsur.2017.01.076 - DOI - PubMed
1. Hattori A, Matsunaga T, Takamochi K, et al. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer. Ann Thorac Surg 2016;102:407-15. 10.1016/j.athoracsur.2016.02.074 - DOI - PubMed
1. Hattori A, Suzuki K, Matsunaga T, et al. Is limited resection appropriate for radiologically "solid" tumors in small lung cancers? Ann Thorac Surg 2012;94:212-5. 10.1016/j.athoracsur.2012.03.033 - DOI - PubMed
1. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85. 10.1097/JTO.0b013e318206a221 - DOI - PMC - PubMed
1. Eguchi T, Kadota K, Park BJ, et al. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 2014;26:210-22. 10.1053/j.semtcvs.2014.09.002 - DOI - PMC - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Hattori A, Matsunaga T, Takamochi K, et al. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Ann Thorac Surg 2017;104:313-20. 10.1016/j.athoracsur.2017.01.076 - DOI - PubMed

[2] Hattori A, Matsunaga T, Takamochi K, et al. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Ann Thorac Surg 2017;104:313-20. 10.1016/j.athoracsur.2017.01.076 - DOI - PubMed

[3] Hattori A, Matsunaga T, Takamochi K, et al. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer. Ann Thorac Surg 2016;102:407-15. 10.1016/j.athoracsur.2016.02.074 - DOI - PubMed

[4] Hattori A, Matsunaga T, Takamochi K, et al. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer. Ann Thorac Surg 2016;102:407-15. 10.1016/j.athoracsur.2016.02.074 - DOI - PubMed

[5] Hattori A, Suzuki K, Matsunaga T, et al. Is limited resection appropriate for radiologically "solid" tumors in small lung cancers? Ann Thorac Surg 2012;94:212-5. 10.1016/j.athoracsur.2012.03.033 - DOI - PubMed

[6] Hattori A, Suzuki K, Matsunaga T, et al. Is limited resection appropriate for radiologically "solid" tumors in small lung cancers? Ann Thorac Surg 2012;94:212-5. 10.1016/j.athoracsur.2012.03.033 - DOI - PubMed

[7] Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85. 10.1097/JTO.0b013e318206a221 - DOI - PMC - PubMed

[8] Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85. 10.1097/JTO.0b013e318206a221 - DOI - PMC - PubMed

[9] Eguchi T, Kadota K, Park BJ, et al. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 2014;26:210-22. 10.1053/j.semtcvs.2014.09.002 - DOI - PMC - PubMed

[10] Eguchi T, Kadota K, Park BJ, et al. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 2014;26:210-22. 10.1053/j.semtcvs.2014.09.002 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Screening-detected pure ground-glass opacities: malignant potential beyond conventional belief?

Affiliation

Screening-detected pure ground-glass opacities: malignant potential beyond conventional belief?

Authors

Affiliation

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources